J Clin Oncol 2014 May 1
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Related Questions
Two new phase 2 studies this year with apatinib/oral etoposide (AEROC) and sorafenib/topotecan (TRIAS) were released, and NCCN also lists many single ...
New comment by at VA Boston Healthcare System ( January 15, 2019)
i agree
Patient has been treated with carbo/taxol, hormonal therapies, and trametinib to date.
New answer by at UCLA David Geffen School of Medicine/UCLA Medical Center (October 19, 2020)
A couple of things to consider for this case, #1 treatment-free interval #2 platinum-free interval #3 bulky disease? #4 recent tumor profiling #5 HRD status? I am assuming tha...